Target intelligence / Profile preview

Kinesin family member 26B (KIF26B)

Target
KIF26B
Molecular classification
Kinesin superfamily protein, Kinesin-11 family, Microtubule-associated protein, Intracellular motor protein
01

Overview

Kinesin family member 26B (KIF26B) is a large, evolutionarily conserved protein of the kinesin superfamily, specifically classified within the Kinesin-11 family[2][4][7]. Unlike conventional kinesins, KIF26B associates with microtubules but lacks canonical ATP-dependent motility[2]. It plays a critical role in embryonic development, including kidney morphogenesis, neural development, and endothelial cell polarity[1][2][4][8]. KIF26B is regulated by the Wnt5a-Ror noncanonical signaling pathway, which modulates its cellular stability via ubiquitin-proteasome-mediated degradation[7]. It influences cell migration, adhesion, and polarity, often localizing to the trailing edge of migrating cells[4][7]. Dysregulation or mutation of KIF26B is associated with various congenital abnormalities and is emerging as an independent prognostic biomarker and potential therapeutic target in several cancers, although there are currently no specific targeted therapeutics approved[5]. The protein's essential function in organogenesis raises safety concerns regarding potential developmental toxicity if directly inhibited.

Other names
Kinesin-like protein KIF26BFLJ10157KIF26B
02

Biological functions

Embryonic developmentCell migrationRegulation of cell polarityMicrotubule stabilizationRegulation of adhesion between mesenchymal cells and ureteric budsKidney development
03

Disease associations

Cancer (including breast, liver, gastric, and colorectal cancers)Developmental disorders (e.g., pontocerebellar hypoplasia, kidney agenesis)Possibly involved in neurological diseases
04

Safety considerations

As an essential developmental gene, inhibition may disrupt embryogenesis or organ formationPotential developmental toxicity if targeted systemically
05

Biomarkers

Overexpression is a potential prognostic biomarker in cancers including colorectal cancerMay be associated with tumor progression, metastasis, and immune infiltration in tumors

Beyond the preview

Go deeper on Kinesin family member 26B (KIF26B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin family member 26B (KIF26B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call